Novel preclinical drug could have potential to combat depression, brain injury and cognitive disorders

-
Scientists have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition. The drug, which notably is brain-permeable, acts to inhibit the kinase enzyme Cdk5.
http://dlvr.it/SQm7h4

Yorumlar

Yorum Gönder

Bu blogdaki popüler yayınlar

Reducing 'vivid imagery' that fuels addiction cravings

-
Resim
New research shows promise in treating addiction cravings by combining eye movements and guided instructions to process memories. Researchers transformed dysfunctional memories stored in the brain through processing and integration. EMDR was as effective as cognitive behavioral therapy for cravings with the combination of both resulting in more reduction in craving than cognitive behavioral therapy (CBT) alone. Both groups (experimental group and control group using only CBT) had clinically significant reductions in cravings, repetitive negative thoughts, and irrational cognitions, with the experimental group showing greater decreases overall.   http://dlvr.it/SyzZrK
Devamı

Penny for your thoughts? Master copper regulator discovery may offer Alzheimer's clues

-
Resim
A study using a tiny roundworm could pave the way for new treatments for neurodegenerative disorders. Researchers linked the worm gene swip-10 to copper regulation -- a vital element for brain health found in everyday items like wiring and cookware. Understanding the roles of swip-10 and MBLAC1, a protein involved in processing cellular materials, could lead to the development of effective medications for neurodegenerative diseases. This research opens new avenues for advancing brain disease treatments. http://dlvr.it/TDZpjl
Devamı